As of Jan 17, 2025, Merck & Co., Inc.'s fair value using the Peter Lynch formula is $3,441.7 per share. The current price of $97.9 suggests Merck & Co., Inc. may be undervalued by this metric.
As of Jan 17, 2025, Merck & Co., Inc.'s P/E ratio is 20.4x. This is calculated by dividing the current share price of $97.9 by the Earnings per Share (EPS) for the trailing twelve months, which is $4.8. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
Merck & Co., Inc. earnings per share (EPS) for the twelve months ending Jan 17, 2025, was $4.8, a 714.2% growth year-over-year.